This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LOUIS CHARGIN, M.D.

Arch Derm Syphilol. 1940;42(2):248-252.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This communication deals, in brief, with the toxic manifestations observed in 270 patients treated with mapharsen in various dosages by the drip method of therapy.

The toxic manifestations in 111 patients treated with neoarsphenamine have already been reported.¹ In the neoarsphenamine series, there were one fatality due to hemorrhagic encephalitis and a rather high incidence of polyneuritis (38 per cent). This led us to the substitution for neoarsphenamine of another arsenical, namely, mapharsen, which we had reason to believe might prove less toxic and perhaps equally efficacious therapeutically, if we were to judge by our experience with a large series of patients with early syphilis treated by the routine method.

In the 270 patients for whom treatment with mapharsen has been completed, there has been no death due to the treatment. In 1 patient in the series hemorrhagic encephalitis developed, which will be discussed later. With this single exception . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Footnotes
Read at a Conference on Massive Arsenotherapy in Early Syphilis by the Continuous Intravenous Drip Method at Mount Sinai Hospital, New York, April 12, 1940.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?